from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2469c/-

LFCtreatmentdescriptionclass of inhibitor

-0.615

Amikacinug/mL Amikacintranslation

-0.975

Cap5-10ug/mL Capreomycintranslation

-0.824

Rox10-50 ug/mL Roxithromycintranslation

-0.878

SM2-5 ug/mL Streptomycintranslation

-0.375

Tet5-10 ug/mL Tetracyclinetranslation

0.454

Rif0.2-5ug/mL Rifampicintranscription

0.144

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.306

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.077

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.004

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.014

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.553

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.641

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.094

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.795

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.460

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.222

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.596

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.028

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.763

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.962

KCN5-20 ug/mL Potassium cyaniderespiration

-0.188

NaN30.2-2 mM Sodium aziderespiration

-0.200

Nigericin50 uM Nigericinrespiration

0.506

TRC10-150 ug/mL Triclosanrespiration

0.997

TRZ10-25 ug/mL Thioridazinerespiration

0.749

Valinomycin0.5-10 uM Valinomycinrespiration

-1.935

ZnSO42 mM ZnSO4respiration

1.345

menadione6-10 ug/mL Menadionerespiration

-0.204

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.455

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.757

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.315

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.171

NRP_1Non-replicating persistence stage 1dosRassociated

-0.156

Amp0.2mg/mL AmpicillincellWall

-0.599

Cephalexin20-100 ug/mL CephalexincellWall

-0.546

Cerulenin0.32-5 ug/mL CerulenincellWall

0.168

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.323

EMB10-20 ug/mL EthambutolcellWall

-1.634

Eta12-40 ug/mL EthionamidecellWall

-1.889

INH0.2-0.4 ug/mL IsoniazidcellWall

0.106

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.334

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.415

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.040

BZA0.12 mg/mL BenzamidearomaticAmides

-0.641

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.739

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.442

H2O24 mM hydrogen peroxideDNAdamaging

-0.231

Levo10 ug/mL LevofloxacinDNAdamaging

-0.234

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.081

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.575

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.111

UVUV-irradiationDNAdamaging

1.309

ARP41-4 ug/mL Antitubercular compound ARP4?

0.193

Antimycin12.5-50 ug/mL Antimycin A?

0.812

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.404

PA_110-50 ug/mL Antitubercular compound PA-1?

0.198

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.490

PA8240.2-2 ug/mL PA-824?

-0.013

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.333

Verapamil50 uM Verapamil?

-0.045

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.076

methoxatin10-20 ug/mL Methoxatin?